Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.55 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.52 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.52 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.52 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.52 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 11/20 | 0.51 |
| ▸ | CDC25B | P30305 | 8/20 | 0.51 |
| ▸ | SELP | P16109 | 2/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 5/20 | 0.48 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.48 |
| ▸ | TACR2 | P21452 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11581477 | 1.00 | NT5E (0.55) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL11584750 | 1.00 | NT5E (0.55) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL28516242 | 0.87 | NT5E (0.60) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL8824434 | 0.87 | PTPN1 (0.50) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL3756791 | 0.86 | SSTR1 (0.46) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL12380712 | 0.84 | VEGFA (0.50) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL10951219 | 0.83 | NT5E (0.54) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL8577146 | 0.83 | SSTR4 (0.63) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL10910569 | 0.83 | NT5E (0.60) | NT5ESSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL20473799 | 0.82 | NT5E (0.62) | NT5ESSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6306828-B1 | ENTERIC OR PARENTAL SOLUTION OF ALPHA-AND/OR BETA-D-GLUCOPYRANOSYL C2-C20 ALKANOATE; WOUND HEALING AGENTS; DIETETICS; TRAUMAS, METABOLIC DISORDERS | BAXTER INTERNATIONAL, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-0736256-B1 | Enantiomerically-enhanced nutritional energy substrates | BAXTER INT (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0736256-A1 | Enantiomerically-enhanced nutritional energy substrates | CLINTEC NUTRITION COMPANY (US) | 1996-10-09 | — | — | EP | disclosed |